Cargando…
Real-Life Experience With Subcutaneous Plasma-Derived C1-Inhibitor for Long-Term Prophylaxis in Patients With Hereditary Angioedema: A Case Series
Hereditary angioedema due to C1-inhibitor deficiency (C1-INH-HAE) is characterized by swelling attacks that may be even life-threatening. To reduce the frequency of attacks, some patients need a long-term prophylaxis (LTP). In addition to the intravenous administration, plasma-derived C1-inhibitor (...
Autores principales: | Zanichelli, Andrea, Suffritti, Chiara, Popescu Janu, Valentina, Merlo, Andrea, Cogliati, Chiara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361474/ https://www.ncbi.nlm.nih.gov/pubmed/35958941 http://dx.doi.org/10.3389/falgy.2022.818741 |
Ejemplares similares
-
Hereditary angioedema: Assessing the hypothesis for underlying autonomic dysfunction
por: Wu, Maddalena A., et al.
Publicado: (2017) -
The complex role of kininogens in hereditary angioedema
por: Kaplan, Allen P., et al.
Publicado: (2022) -
Pregnancy in Patients With Hereditary Angioedema and Normal C1 Inhibitor
por: Gabriel, Natalia, et al.
Publicado: (2022) -
Treatment of hereditary angioedema—single or multiple pathways to the rescue
por: Valerieva, Anna, et al.
Publicado: (2022) -
Individual approach to long-term therapy in patients with hereditary angioedema (HAE-C1-INH): A case series
por: Andarawewa, S., et al.
Publicado: (2022)